APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Voriconazole

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Voriconazole Industry Growth and Trends Forecast to 2032

27 December 2025110 pages

Choose your research edition.

Industry ResearchOral Voriconazole Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Voriconazole Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Oral Voriconazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Voriconazole Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Voriconazole Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Oral Voriconazole market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Oral Voriconazole market include Zhuhai Rundu Pharmaceutical, Yangzijiang Pharmaceutical Group, Poly Pharm, Union-Bio science, Huahai Pharmaceutical, Brilliant Pharmaceuticals, Beijing Genetech Pharmaceutical, Viona Pharmaceuticals and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Voriconazole market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Voriconazole market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Voriconazole market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Voriconazole.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Oral Voriconazole market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Voriconazole Market by Company

Zhuhai Rundu Pharmaceutical

Yangzijiang Pharmaceutical Group

Poly Pharm

Union-Bio science

Huahai Pharmaceutical

Brilliant Pharmaceuticals

Beijing Genetech Pharmaceutical

Viona Pharmaceuticals

Teva

Taj Pharmaceuticals

Sun Pharmaceutical

SiNi Pharma

Sandoz

Pfizer

Lupin Pharmaceuticals

Oral Voriconazole Segment by Type

Voriconazole Suspension

Voriconazole Capsules

Voriconazole Tablets

Oral Voriconazole Segment by Application

Hospital Pharmacy

Retail Pharmacy

Oral Voriconazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Voriconazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Voriconazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Voriconazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Oral Voriconazole companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Oral Voriconazole Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Oral Voriconazole Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Oral Voriconazole Market Share by Region (2021-2026) Table 4. Global Oral Voriconazole Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Oral Voriconazole Market Share by Region (2027-2032) Table 6. Global Oral Voriconazole Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Oral Voriconazole Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Oral Voriconazole Market Size Share by Type (2021-2026) Table 9. Global Oral Voriconazole Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Oral Voriconazole Market Size Share Forecasted by Type (2027-2032) Table 11. North America Oral Voriconazole Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Oral Voriconazole Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Oral Voriconazole Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Oral Voriconazole Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Oral Voriconazole Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Oral Voriconazole Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Oral Voriconazole Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Oral Voriconazole Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Oral Voriconazole Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Oral Voriconazole Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Oral Voriconazole Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Oral Voriconazole Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Oral Voriconazole Market Size Share by Application (2021-2026) Table 24. Global Oral Voriconazole Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Oral Voriconazole Market Size Share Forecasted by Application (2027-2032) Table 26. North America Oral Voriconazole Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Oral Voriconazole Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Oral Voriconazole Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Oral Voriconazole Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Oral Voriconazole Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Oral Voriconazole Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Oral Voriconazole Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Oral Voriconazole Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Oral Voriconazole Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Oral Voriconazole Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Oral Voriconazole Industry Trends Table 37. Oral Voriconazole Industry Drivers Table 38. Oral Voriconazole Industry Opportunities and Challenges Table 39. Oral Voriconazole Industry Restraints Table 40. Global Oral Voriconazole Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Oral Voriconazole Revenue Market Share by Company (2021-2026) Table 42. Global Oral Voriconazole Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Oral Voriconazole Key Company Headquarters & Area Served Table 44. Global Oral Voriconazole Company, Product Type & Application Table 45. Global Oral Voriconazole Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Oral Voriconazole by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Zhuhai Rundu Pharmaceutical Company Information Table 49. Zhuhai Rundu Pharmaceutical Business Overview Table 50. Zhuhai Rundu Pharmaceutical Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Zhuhai Rundu Pharmaceutical Oral Voriconazole Product Portfolio Table 52. Zhuhai Rundu Pharmaceutical Recent Development Table 53. Yangzijiang Pharmaceutical Group Company Information Table 54. Yangzijiang Pharmaceutical Group Business Overview Table 55. Yangzijiang Pharmaceutical Group Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Yangzijiang Pharmaceutical Group Oral Voriconazole Product Portfolio Table 57. Yangzijiang Pharmaceutical Group Recent Development Table 58. Poly Pharm Company Information Table 59. Poly Pharm Business Overview Table 60. Poly Pharm Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Poly Pharm Oral Voriconazole Product Portfolio Table 62. Poly Pharm Recent Development Table 63. Union-Bio science Company Information Table 64. Union-Bio science Business Overview Table 65. Union-Bio science Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Union-Bio science Oral Voriconazole Product Portfolio Table 67. Union-Bio science Recent Development Table 68. Huahai Pharmaceutical Company Information Table 69. Huahai Pharmaceutical Business Overview Table 70. Huahai Pharmaceutical Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Huahai Pharmaceutical Oral Voriconazole Product Portfolio Table 72. Huahai Pharmaceutical Recent Development Table 73. Brilliant Pharmaceuticals Company Information Table 74. Brilliant Pharmaceuticals Business Overview Table 75. Brilliant Pharmaceuticals Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Brilliant Pharmaceuticals Oral Voriconazole Product Portfolio Table 77. Brilliant Pharmaceuticals Recent Development Table 78. Beijing Genetech Pharmaceutical Company Information Table 79. Beijing Genetech Pharmaceutical Business Overview Table 80. Beijing Genetech Pharmaceutical Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Beijing Genetech Pharmaceutical Oral Voriconazole Product Portfolio Table 82. Beijing Genetech Pharmaceutical Recent Development Table 83. Viona Pharmaceuticals Company Information Table 84. Viona Pharmaceuticals Business Overview Table 85. Viona Pharmaceuticals Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Viona Pharmaceuticals Oral Voriconazole Product Portfolio Table 87. Viona Pharmaceuticals Recent Development Table 88. Teva Company Information Table 89. Teva Business Overview Table 90. Teva Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Teva Oral Voriconazole Product Portfolio Table 92. Teva Recent Development Table 93. Taj Pharmaceuticals Company Information Table 94. Taj Pharmaceuticals Business Overview Table 95. Taj Pharmaceuticals Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Taj Pharmaceuticals Oral Voriconazole Product Portfolio Table 97. Taj Pharmaceuticals Recent Development Table 98. Sun Pharmaceutical Company Information Table 99. Sun Pharmaceutical Business Overview Table 100. Sun Pharmaceutical Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sun Pharmaceutical Oral Voriconazole Product Portfolio Table 102. Sun Pharmaceutical Recent Development Table 103. SiNi Pharma Company Information Table 104. SiNi Pharma Business Overview Table 105. SiNi Pharma Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. SiNi Pharma Oral Voriconazole Product Portfolio Table 107. SiNi Pharma Recent Development Table 108. Sandoz Company Information Table 109. Sandoz Business Overview Table 110. Sandoz Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Sandoz Oral Voriconazole Product Portfolio Table 112. Sandoz Recent Development Table 113. Pfizer Company Information Table 114. Pfizer Business Overview Table 115. Pfizer Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Pfizer Oral Voriconazole Product Portfolio Table 117. Pfizer Recent Development Table 118. Lupin Pharmaceuticals Company Information Table 119. Lupin Pharmaceuticals Business Overview Table 120. Lupin Pharmaceuticals Oral Voriconazole Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Lupin Pharmaceuticals Oral Voriconazole Product Portfolio Table 122. Lupin Pharmaceuticals Recent Development Table 123. North America Oral Voriconazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Oral Voriconazole Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Oral Voriconazole Market Share by Country (2021-2026) Table 126. North America Oral Voriconazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Oral Voriconazole Market Share Forecast by Country (2027-2032) Table 128. Europe Oral Voriconazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Oral Voriconazole Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Oral Voriconazole Market Share by Country (2021-2026) Table 131. Europe Oral Voriconazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Oral Voriconazole Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Oral Voriconazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Oral Voriconazole Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Oral Voriconazole Market Share by Country (2021-2026) Table 136. Asia-Pacific Oral Voriconazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Oral Voriconazole Market Share Forecast by Country (2027-2032) Table 138. Latin America Oral Voriconazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Oral Voriconazole Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Oral Voriconazole Market Share by Country (2021-2026) Table 141. Latin America Oral Voriconazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Oral Voriconazole Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Oral Voriconazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Oral Voriconazole Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Oral Voriconazole Market Share by Country (2021-2026) Table 146. Middle East & Africa Oral Voriconazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Oral Voriconazole Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Oral Voriconazole Product Image Figure 3. Global Oral Voriconazole Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Oral Voriconazole Market Size (2021-2032) & (US$ Million) Figure 5. Global Oral Voriconazole Market Share by Region: 2025 VS 2032 Figure 6. Global Oral Voriconazole Market Share by Region (2021-2032) Figure 7. North America Oral Voriconazole Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Oral Voriconazole Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Oral Voriconazole Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Oral Voriconazole Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Oral Voriconazole Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Voriconazole Suspension Image Figure 13. Global Voriconazole Suspension Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Voriconazole Capsules Image Figure 15. Global Voriconazole Capsules Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Voriconazole Tablets Image Figure 17. Global Voriconazole Tablets Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Oral Voriconazole Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Oral Voriconazole Market Share by Type 2025 VS 2032 Figure 20. North America Oral Voriconazole Market Size Share by Type (2021-2032) Figure 21. Europe Oral Voriconazole Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Oral Voriconazole Market Size Share by Type (2021-2032) Figure 23. Latin America Oral Voriconazole Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Oral Voriconazole Market Size Share by Type (2021-2032) Figure 25. Hospital Pharmacy Image Figure 26. Global Hospital Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Oral Voriconazole Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Oral Voriconazole Market Share by Application 2025 VS 2032 Figure 31. North America Oral Voriconazole Market Size Share by Application (2021-2032) Figure 32. Europe Oral Voriconazole Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Oral Voriconazole Market Size Share by Application (2021-2032) Figure 34. Latin America Oral Voriconazole Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Oral Voriconazole Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Oral Voriconazole Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Oral Voriconazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Oral Voriconazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Oral Voriconazole Market Share by Country (2021-2032) Figure 41. Europe Oral Voriconazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Oral Voriconazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Oral Voriconazole Market Share by Country (2021-2032) Figure 44. Asia-Pacific Oral Voriconazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Oral Voriconazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Oral Voriconazole Market Share by Country (2021-2032) Figure 47. Latin America Oral Voriconazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Oral Voriconazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Oral Voriconazole Market Share by Country (2021-2032) Figure 50. Middle East & Africa Oral Voriconazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Oral Voriconazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Oral Voriconazole Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Voriconazole Suspension
  • Voriconazole Capsules
  • Voriconazole Tablets
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • Zhuhai Rundu Pharmaceutical
  • Yangzijiang Pharmaceutical Group
  • Poly Pharm
  • Union-Bio science
  • Huahai Pharmaceutical
  • Brilliant Pharmaceuticals
  • Beijing Genetech Pharmaceutical
  • Viona Pharmaceuticals
  • Teva
  • Taj Pharmaceuticals
  • Sun Pharmaceutical
  • SiNi Pharma
  • Sandoz
  • Pfizer
  • Lupin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Oral Voriconazole Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Oral Voriconazole Market Size by Region (2021-2032)
  5. 1.4.1 Global Oral Voriconazole Market Size by Region (2021-2026)
  6. 1.4.2 Global Oral Voriconazole Market Size by Region (2027-2032)
  7. 1.5 Key Regions Oral Voriconazole Market Size (2021-2032)
  8. 1.5.1 North America Oral Voriconazole Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Oral Voriconazole Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Oral Voriconazole Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Oral Voriconazole Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Oral Voriconazole Market Size Growth Rate (2021-2032)
2 Oral Voriconazole Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Voriconazole Suspension
  3. 2.1.2 Voriconazole Capsules
  4. 2.1.3 Voriconazole Tablets
  5. 2.2 Global Oral Voriconazole Market Size by Type
  6. 2.2.1 Global Oral Voriconazole Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Oral Voriconazole Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Oral Voriconazole Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Oral Voriconazole Market Size by Regions
  10. 2.3.1 North America Oral Voriconazole Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Oral Voriconazole Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Oral Voriconazole Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Oral Voriconazole Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Oral Voriconazole Market Size Breakdown by Type (2021-2026)
3 Oral Voriconazole Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacy
  3. 3.1.2 Retail Pharmacy
  4. 3.2 Global Oral Voriconazole Market Size by Application
  5. 3.2.1 Global Oral Voriconazole Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Oral Voriconazole Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Oral Voriconazole Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Oral Voriconazole Market Size by Regions
  9. 3.3.1 North America Oral Voriconazole Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Oral Voriconazole Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Oral Voriconazole Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Oral Voriconazole Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Oral Voriconazole Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Oral Voriconazole Industry Trends
  2. 4.2 Oral Voriconazole Industry Drivers
  3. 4.3 Oral Voriconazole Industry Opportunities and Challenges
  4. 4.4 Oral Voriconazole Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Oral Voriconazole Revenue (2021-2026)
  2. 5.2 Global Oral Voriconazole Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Oral Voriconazole Key Company Headquarters & Area Served
  4. 5.4 Global Oral Voriconazole Company, Product Type & Application
  5. 5.5 Global Oral Voriconazole Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Oral Voriconazole Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Oral Voriconazole Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Oral Voriconazole Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Zhuhai Rundu Pharmaceutical
  2. 6.1.1 Zhuhai Rundu Pharmaceutical Company Information
  3. 6.1.2 Zhuhai Rundu Pharmaceutical Business Overview
  4. 6.1.3 Zhuhai Rundu Pharmaceutical Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Zhuhai Rundu Pharmaceutical Oral Voriconazole Product Portfolio
  6. 6.1.5 Zhuhai Rundu Pharmaceutical Recent Developments
  7. 6.2 Yangzijiang Pharmaceutical Group
  8. 6.2.1 Yangzijiang Pharmaceutical Group Company Information
  9. 6.2.2 Yangzijiang Pharmaceutical Group Business Overview
  10. 6.2.3 Yangzijiang Pharmaceutical Group Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Yangzijiang Pharmaceutical Group Oral Voriconazole Product Portfolio
  12. 6.2.5 Yangzijiang Pharmaceutical Group Recent Developments
  13. 6.3 Poly Pharm
  14. 6.3.1 Poly Pharm Company Information
  15. 6.3.2 Poly Pharm Business Overview
  16. 6.3.3 Poly Pharm Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Poly Pharm Oral Voriconazole Product Portfolio
  18. 6.3.5 Poly Pharm Recent Developments
  19. 6.4 Union-Bio science
  20. 6.4.1 Union-Bio science Company Information
  21. 6.4.2 Union-Bio science Business Overview
  22. 6.4.3 Union-Bio science Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Union-Bio science Oral Voriconazole Product Portfolio
  24. 6.4.5 Union-Bio science Recent Developments
  25. 6.5 Huahai Pharmaceutical
  26. 6.5.1 Huahai Pharmaceutical Company Information
  27. 6.5.2 Huahai Pharmaceutical Business Overview
  28. 6.5.3 Huahai Pharmaceutical Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Huahai Pharmaceutical Oral Voriconazole Product Portfolio
  30. 6.5.5 Huahai Pharmaceutical Recent Developments
  31. 6.6 Brilliant Pharmaceuticals
  32. 6.6.1 Brilliant Pharmaceuticals Company Information
  33. 6.6.2 Brilliant Pharmaceuticals Business Overview
  34. 6.6.3 Brilliant Pharmaceuticals Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Brilliant Pharmaceuticals Oral Voriconazole Product Portfolio
  36. 6.6.5 Brilliant Pharmaceuticals Recent Developments
  37. 6.7 Beijing Genetech Pharmaceutical
  38. 6.7.1 Beijing Genetech Pharmaceutical Company Information
  39. 6.7.2 Beijing Genetech Pharmaceutical Business Overview
  40. 6.7.3 Beijing Genetech Pharmaceutical Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Beijing Genetech Pharmaceutical Oral Voriconazole Product Portfolio
  42. 6.7.5 Beijing Genetech Pharmaceutical Recent Developments
  43. 6.8 Viona Pharmaceuticals
  44. 6.8.1 Viona Pharmaceuticals Company Information
  45. 6.8.2 Viona Pharmaceuticals Business Overview
  46. 6.8.3 Viona Pharmaceuticals Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Viona Pharmaceuticals Oral Voriconazole Product Portfolio
  48. 6.8.5 Viona Pharmaceuticals Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Teva Oral Voriconazole Product Portfolio
  54. 6.9.5 Teva Recent Developments
  55. 6.10 Taj Pharmaceuticals
  56. 6.10.1 Taj Pharmaceuticals Company Information
  57. 6.10.2 Taj Pharmaceuticals Business Overview
  58. 6.10.3 Taj Pharmaceuticals Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Taj Pharmaceuticals Oral Voriconazole Product Portfolio
  60. 6.10.5 Taj Pharmaceuticals Recent Developments
  61. 6.11 Sun Pharmaceutical
  62. 6.11.1 Sun Pharmaceutical Company Information
  63. 6.11.2 Sun Pharmaceutical Business Overview
  64. 6.11.3 Sun Pharmaceutical Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sun Pharmaceutical Oral Voriconazole Product Portfolio
  66. 6.11.5 Sun Pharmaceutical Recent Developments
  67. 6.12 SiNi Pharma
  68. 6.12.1 SiNi Pharma Company Information
  69. 6.12.2 SiNi Pharma Business Overview
  70. 6.12.3 SiNi Pharma Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 SiNi Pharma Oral Voriconazole Product Portfolio
  72. 6.12.5 SiNi Pharma Recent Developments
  73. 6.13 Sandoz
  74. 6.13.1 Sandoz Company Information
  75. 6.13.2 Sandoz Business Overview
  76. 6.13.3 Sandoz Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Sandoz Oral Voriconazole Product Portfolio
  78. 6.13.5 Sandoz Recent Developments
  79. 6.14 Pfizer
  80. 6.14.1 Pfizer Company Information
  81. 6.14.2 Pfizer Business Overview
  82. 6.14.3 Pfizer Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Pfizer Oral Voriconazole Product Portfolio
  84. 6.14.5 Pfizer Recent Developments
  85. 6.15 Lupin Pharmaceuticals
  86. 6.15.1 Lupin Pharmaceuticals Company Information
  87. 6.15.2 Lupin Pharmaceuticals Business Overview
  88. 6.15.3 Lupin Pharmaceuticals Oral Voriconazole Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Lupin Pharmaceuticals Oral Voriconazole Product Portfolio
  90. 6.15.5 Lupin Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Oral Voriconazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Oral Voriconazole Market Size by Country (2021-2026)
  3. 7.3 North America Oral Voriconazole Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Oral Voriconazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Oral Voriconazole Market Size by Country (2021-2026)
  3. 8.3 Europe Oral Voriconazole Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Oral Voriconazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Oral Voriconazole Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Oral Voriconazole Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Oral Voriconazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Oral Voriconazole Market Size by Country (2021-2026)
  3. 10.3 South America Oral Voriconazole Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Oral Voriconazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Oral Voriconazole Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Oral Voriconazole Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst